{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:19Z","timestamp":1792787899781,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Administration of the Basic and Applied Basic Research Foundation of Guangdong Province","award":["2022A1515220194"],"award-info":[{"award-number":["2022A1515220194"]}]},{"name":"the Guangdong Province Science and Technology Innovation Strategy Special Fund","award":["pdjh2023b1059"],"award-info":[{"award-number":["pdjh2023b1059"]}]},{"name":"the Medical Research Fund of Guangdong Province","award":["A2024543"],"award-info":[{"award-number":["A2024543"]}]},{"name":"the Medical Research Fund of Guangdong Province","award":["B2023280"],"award-info":[{"award-number":["B2023280"]}]},{"name":"the Zhaoqing Medical College Fund for Young Talent","award":["Zqyq22-005"],"award-info":[{"award-number":["Zqyq22-005"]}],"id":[{"id":"https:\/\/ror.org\/05ht1zd86","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Zhaoqing Medical College Fund for Young Talent","award":["Zqyq22-007"],"award-info":[{"award-number":["Zqyq22-007"]}],"id":[{"id":"https:\/\/ror.org\/05ht1zd86","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Traditional Chinese Medicine Bureau of Guangdong Province","award":["20231403"],"award-info":[{"award-number":["20231403"]}],"id":[{"id":"https:\/\/ror.org\/05vkkzf98","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Scientific Research Fund of the First People\u2019s Hospital of Zhaoqing","award":["YJJ-2023-02-04"],"award-info":[{"award-number":["YJJ-2023-02-04"]}],"id":[{"id":"https:\/\/ror.org\/04gcfwh66","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05146-0","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:25:54Z","timestamp":1784280354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FBXW8 is upregulated in hepatocellular carcinoma and promotes HCC cell malignancy"],"prefix":"10.1186","volume":"26","author":[{"given":"Duanzhuo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6061-2126","authenticated-orcid":false,"given":"Mi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"11","key":"5146_CR1","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1631\/jzus.B1900343","volume":"20","author":"Y Dai","year":"2019","unstructured":"Dai Y, Shen JL, Zheng XY, Lin TY, Yu HT. Integrated analysis of hypoxia-induced miR-210 signature as a potential prognostic biomarker of hepatocellular carcinoma: a study based on The Cancer Genome Atlas. J Zhejiang Univ Sci B. 2019;20(11):928\u201332. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31595729.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"3","key":"5146_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38572751.","journal-title":"Cancer J Clin"},{"issue":"7","key":"5146_CR3","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1200\/JCO.22.00620","volume":"41","author":"S Qin","year":"2023","unstructured":"Qin S, Chen Z, Fang W, Ren Z, Xu R, Ryoo BY, et al. Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial. J Clin oncology: official J Am Soc Clin Oncol. 2023;41(7):1434\u201343. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36455168.","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"issue":"4","key":"5146_CR4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ijrobp.2014.02.017","volume":"89","author":"JM Vainshtein","year":"2014","unstructured":"Vainshtein JM, Kabarriti R, Mehta KJ, Roy-Chowdhury J, Guha C. Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2014;89(4):786\u2013803. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24969793.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"5146_CR5","doi-asserted-by":"publisher","first-page":"EVIDoa2100070","DOI":"10.1056\/EVIDoa2100070","volume":"1","author":"GK Abou-Alfa","year":"2022","unstructured":"Abou-Alfa GK, Lau G, Kudo M, Chan SL, Kelley RK, Furuse J, et al. Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma. NEJM Evid. 2022;1(8):EVIDoa2100070. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38319892.","journal-title":"NEJM Evid"},{"key":"5146_CR6","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/JHC.S556306","volume":"12","author":"WL Luo","year":"2025","unstructured":"Luo WL, Wang QB, Li YK, Liang YB, Li J, Chen XM, et al. Impact of Middle Hepatic Vein Resection During Hemihepatectomy on Surgical Outcomes and Long-Term Prognosis in Hepatocellular Carcinoma: A Retrospective Study. J hepatocellular carcinoma. 2025;12:2681\u201392. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/41383360.","journal-title":"J hepatocellular carcinoma"},{"key":"5146_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.11604\/pamj.2017.27.41.9584","volume":"27","author":"F Limaiem","year":"2017","unstructured":"Limaiem F, Bouhamed M, Sahraoui G, Mzabi S. Hepatocellular carcinoma: a clinicopathological study of 64 cases. Pan Afr Med J. 2017;27:41. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28761617.","journal-title":"Pan Afr Med J"},{"issue":"26","key":"5146_CR8","doi-asserted-by":"publisher","first-page":"e34165","DOI":"10.1097\/MD.0000000000034165","volume":"102","author":"J Xu","year":"2023","unstructured":"Xu J, Shan Y, Zhang C, Hong Z, Qiu Y. Effect of Chinese Medicines combined with transarterial chemoembolization on primary hepatic carcinoma: A systematic review and meta-analysis. Medicine. 2023;102(26):e34165. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37390274.","journal-title":"Medicine"},{"key":"5146_CR9","doi-asserted-by":"crossref","unstructured":"Yalcin S, Lacin S, Kaseb AO, Peynircioglu B, Cantasdemir M, Cil BE et al. A Post-International Gastrointestinal Cancers\u2019 Conference (IGICC) Position Statements. Journal of hepatocellular carcinoma. 2024;11:953\u2009\u2013\u200974. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38832120","DOI":"10.2147\/JHC.S449540"},{"issue":"5","key":"5146_CR10","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3892\/ol.2016.5110","volume":"12","author":"L Li","year":"2016","unstructured":"Li L, Zhao GD, Shi Z, Qi LL, Zhou LY, Fu ZX. The Ras\/Raf\/MEK\/ERK signaling pathway and its role in the occurrence and development of HCC. Oncol Lett. 2016;12(5):3045\u201350. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27899961.","journal-title":"Oncol Lett"},{"issue":"20","key":"5146_CR11","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020;382(20):1894\u2013905. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32402160.","journal-title":"N Engl J Med"},{"issue":"10415","key":"5146_CR12","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(23)01796-8","volume":"402","author":"S Qin","year":"2023","unstructured":"Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, et al. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial. Lancet. 2023;402(10415):1835\u201347. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37871608.","journal-title":"Lancet"},{"key":"5146_CR13","doi-asserted-by":"crossref","unstructured":"Chen XM, Liang YB, Zuo JX, Yang ZS, Zhang LY, Zhang XY et al. ZG16B: A key regulator of tumor progression and immune microenvironment modulation in cancer (Review). Int J Mol Med. 2026;57(3). http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/41543187","DOI":"10.3892\/ijmm.2026.5729"},{"issue":"6","key":"5146_CR14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.5152\/tjg.2019.18654","volume":"30","author":"M Watanabe","year":"2019","unstructured":"Watanabe M, Yokomori H, Takahashi Y, Okada T, Shibuya A, Koizumi W. Assessing the characteristics and feasibility of preventing early mortality in patients with hepatocellular carcinoma. Turkish J gastroenterology: official J Turkish Soc Gastroenterol. 2019;30(6):541\u20138. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31144660.","journal-title":"Turkish J gastroenterology: official J Turkish Soc Gastroenterol"},{"key":"5146_CR15","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/JHC.S544589","volume":"12","author":"QB Wang","year":"2025","unstructured":"Wang QB, Luo WL, Li YK, Li J, Yang ZS, Zhao K, et al. Tumor Compression of the Hepatic or Portal Vein Predicts the Presence of Microvascular Invasion and Satellite Nodules in Hepatocellular Carcinoma: A Retrospective Study. J hepatocellular carcinoma. 2025;12:2055\u201367. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/40963958.","journal-title":"J hepatocellular carcinoma"},{"issue":"10","key":"5146_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","volume":"15","author":"JM Llovet","year":"2018","unstructured":"Llovet JM, Montal R, Sia D, Finn RS. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat reviews Clin Oncol. 2018;15(10):599\u2013616. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30061739.","journal-title":"Nat reviews Clin Oncol"},{"issue":"5","key":"5146_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3322\/caac.21844","volume":"74","author":"V Subbiah","year":"2024","unstructured":"Subbiah V, Gouda MA, Ryll B, Burris HA 3rd, Kurzrock R. The evolving landscape of tissue-agnostic therapies in precision oncology. Cancer J Clin. 2024;74(5):433\u201352. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38814103.","journal-title":"Cancer J Clin"},{"key":"5146_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijbiomac.2021.08.195","volume":"190","author":"S Islam","year":"2021","unstructured":"Islam S, Dutta P, Chopra K, Sahay O, Rapole S, Chauhan R, et al. Co-operative binding of SKP1, Cullin1 and Cullin7 to FBXW8 results in Cullin1-SKP1-FBXW8-Cullin7 functional complex formation that monitors cellular function of beta-TrCP1. Int J Biol Macromol. 2021;190:233\u201343. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34478796.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"5146_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4149\/neo_2021_201207N1324","volume":"68","author":"Y Li","year":"2021","unstructured":"Li Y, Zang A, Fu J, Jia Y. Cullin 7 in tumor development: a novel potential anti-cancer target. Neoplasma. 2021;68(3):572\u20139. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33618520.","journal-title":"Neoplasma"},{"issue":"4","key":"5146_CR20","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.bbrc.2014.06.094","volume":"450","author":"D Shi","year":"2014","unstructured":"Shi D, Tan Z, Lu R, Yang W, Zhang Y. MicroRNA-218 inhibits the proliferation of human choriocarcinoma JEG-3 cell line by targeting Fbxw8. Biochem Biophys Res Commun. 2014;450(4):1241\u20136. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24973709.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5146_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.scr.2014.04.001","volume":"13","author":"SH Kim","year":"2014","unstructured":"Kim SH, Kim MO, Cho YY, Yao K, Kim DJ, Jeong CH, et al. ERK1 phosphorylates Nanog to regulate protein stability and stem cell self-renewal. Stem cell Res. 2014;13(1):1\u201311. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24793005.","journal-title":"Stem cell Res"},{"issue":"4","key":"5146_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314\u20136. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28398314.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"5146_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22455463.","journal-title":"OMICS"},{"issue":"269","key":"5146_CR24","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23550210.","journal-title":"Sci Signal"},{"issue":"8","key":"5146_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017;19(8):649\u201358. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28732212.","journal-title":"Neoplasia"},{"key":"5146_CR26","doi-asserted-by":"crossref","unstructured":"Modhukur V, Iljasenko T, Metsalu T, Lokk K, Laisk-Podar T, Vilo J. Epigenomics. 2018;10(3):277\u201388. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29264942. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data.","DOI":"10.2217\/epi-2017-0118"},{"issue":"4","key":"5146_CR27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24138885.","journal-title":"Immunity"},{"key":"5146_CR28","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24113773.","journal-title":"Nat Commun"},{"issue":"57","key":"5146_CR29","doi-asserted-by":"publisher","first-page":"97178","DOI":"10.18632\/oncotarget.21843","volume":"8","author":"DZ Li","year":"2017","unstructured":"Li DZ, Liu SF, Zhu L, Wang YX, Chen YX, Liu J, et al. FBXW8-dependent degradation of MRFAP1 in anaphase controls mitotic cell death. Oncotarget. 2017;8(57):97178\u201386. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29228602.","journal-title":"Oncotarget"},{"issue":"1","key":"5146_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34635121.","journal-title":"Mol Cancer"},{"issue":"7","key":"5146_CR31","doi-asserted-by":"publisher","first-page":"167985","DOI":"10.1016\/j.bbadis.2025.167985","volume":"1871","author":"J He","year":"2025","unstructured":"He J, Zou X, Wang D, Zhou L, Li X, Ma S, et al. FBXW8-mediated degradation of PPT1 suppresses epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma. Biochim et Biophys acta Mol basis disease. 2025;1871(7):167985. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/40659255.","journal-title":"Biochim et Biophys acta Mol basis disease"},{"issue":"11","key":"5146_CR32","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37(11):1012\u201327. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34120771.","journal-title":"Trends Genet"},{"key":"5146_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-pathol-042220-022304","volume":"17","author":"A Papanicolau-Sengos","year":"2022","unstructured":"Papanicolau-Sengos A, Aldape K. DNA Methylation Profiling: An Emerging Paradigm for Cancer Diagnosis. Annu Rev Pathol. 2022;17:295\u2013321. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34736341.","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"5146_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","volume":"19","author":"M Ringelhan","year":"2018","unstructured":"Ringelhan M, Pfister D, O\u2019Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19(3):222\u201332. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29379119.","journal-title":"Nat Immunol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05146-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05146-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05146-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:03:11Z","timestamp":1791896591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05146-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5146"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05146-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"14 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All analyses that involved human samples were conducted in strict adherence to the relevant ethical regulations. The HCC tissue microarray (ZL-LVC1608) was obtained from Shanghai ZHUOLI Biotech Co., Ltd., which had obtained ethical approval from its institutional review board (Approval No.: SHLLS-BA-22101102). The cDNA samples (LncDNA-HLivH030PG01) were obtained from Shanghai OUTDO Biotech Co., Ltd., which had obtained ethical approval for tissue collection from its institutional review board (Approval No.: SHYJS-CP-1807029). All samples utilized in this study were obtained with the informed consent of the patients and in strict adherence to the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"640"}}